2016
DOI: 10.7476/9788523220051
|View full text |Cite
|
Sign up to set email alerts
|

Saúde para todos, já!

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 7 publications
0
3
0
Order By: Relevance
“…However, cerebrosides are also reported to have neuroprotective activity such that increasing cerebroside levels by altering the de novo synthesis pathway of sphingolipids leads to deactivation of downstream apoptosis signaling pathways. 7,8 These results of different cerebroside levels reflect an incomplete understanding of the physiological roles of cerebrosides. A more complete understanding of this sphingolipid subclass will likely require both differentiation and quantification of the diastereomers in biological milieu.…”
Section: Introductionmentioning
confidence: 99%
“…However, cerebrosides are also reported to have neuroprotective activity such that increasing cerebroside levels by altering the de novo synthesis pathway of sphingolipids leads to deactivation of downstream apoptosis signaling pathways. 7,8 These results of different cerebroside levels reflect an incomplete understanding of the physiological roles of cerebrosides. A more complete understanding of this sphingolipid subclass will likely require both differentiation and quantification of the diastereomers in biological milieu.…”
Section: Introductionmentioning
confidence: 99%
“…Hence a productive discussion of molecular diversity is contingent upon choice of meaningful molecular descriptors. 10 In this Perspective, we emphasize molecular descriptors that differentiate NP space from synthetic collections.…”
Section: Introductionmentioning
confidence: 99%
“…11a If a lead possesses poor physicochemical properties, its optimization begins from a disadvantaged starting point. Falling into this 'local minimum' can prove costly: on average, only small changes occur during optimization between lead and drug candidate, 10 and failure in clinical trials is expensive. On the other hand, if a lead is structurally advantaged but synthetically intractable, its quick advance through medicinal chemistry optimization is unlikely.…”
Section: Introductionmentioning
confidence: 99%